Related Experiment Video
Updated: Jun 21, 2026
12:04
The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
Systemic lupus erythematosus--2005 annus mirabilis?
David Isenberg1, Anisur Rahman
1Center for Rheumatology, University College London Hospitals, London, UK. d.isenberg@ucl.ac.uk
Nature Clinical Practice. Rheumatology
|August 26, 2006
Summary
New treatments offer hope for systemic lupus erythematosus (SLE) patients. Advanced therapies target disease mechanisms, improving outcomes beyond traditional hydroxychloroquine sulfate and corticosteroids.
Area of Science:
- Immunology
- Rheumatology
- Pharmacology
Background:
- Systemic lupus erythematosus (SLE) has historically been managed with hydroxychloroquine sulfate, corticosteroids, and broad immunosuppressants.
- These traditional treatments can be ineffective for some patients and cause significant side effects due to generalized immunosuppression.
Purpose of the Study:
- To review emerging therapies for systemic lupus erythematosus (SLE).
- To highlight advancements in targeted treatments that address specific molecular pathways involved in SLE pathogenesis.
Main Methods:
- Review of current literature on novel SLE therapeutics.
- Analysis of newer immunosuppressive agents and biological agents targeting specific molecules.
Main Results:
- Newer immunosuppressants like mycophenolate mofetil offer improved side effect profiles.
- Biological agents designed to block molecules such as CD20, CD22, and interleukin-10 represent a more targeted therapeutic approach.
Conclusions:
- The landscape of SLE treatment is evolving, moving towards more personalized and effective strategies.
- Emerging therapies show promise in overcoming the limitations of traditional treatments, offering new hope for patients with SLE.
Related Concept Videos
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:30Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...